Armistice Capital, LLC Aligos Therapeutics, Inc. Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,893,410 shares of ALGS stock, worth $2.76 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,893,410
Previous 6,833,875
0.87%
Holding current value
$2.76 Million
Previous $4.51 Million
49.78%
% of portfolio
0.09%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding ALGS
# of Institutions
53Shares Held
46.2MCall Options Held
6.11MPut Options Held
200-
Eco R1 Capital, LLC San Francisco, CA6.39MShares$2.56 Million0.18% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$2.44 Million0.2% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$1.42 Million0.46% of portfolio
-
Altitude Crest Partners Inc. Stamford, CT2.84MShares$1.14 Million1.19% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.46MShares$985,8020.0% of portfolio
About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $15.9M
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...